China Has 5 Vaccine Candidates in Human Trials, With More Coming
China has a total of five possible vaccines for the coronavirus already in human trials and more will be approved next month, signaling the Asian nation’s rapid progress in the race for immunization.
The five vaccines have been tested on more than 2,000 people in phase II trials which are expected to finish in July, said Zeng Yixin, vice minister of the National Health Commission, at a press briefing on Friday in Beijing. Phase II is the second of three phases of human trials that medications must go through before being approved for general use.
No serious side effects have been reported yet among phase II patients, said Zeng, adding that more vaccine candidates will be approved to go into human trials in June.
I am aware of 4 of these vaccines (below). But the article did not name of the 5th vaccine maker.
China has a total of five possible vaccines for the coronavirus already in human trials and more will be approved next month, signaling the Asian nation’s rapid progress in the race for immunization.
The five vaccines have been tested on more than 2,000 people in phase II trials which are expected to finish in July, said Zeng Yixin, vice minister of the National Health Commission, at a press briefing on Friday in Beijing. Phase II is the second of three phases of human trials that medications must go through before being approved for general use.
No serious side effects have been reported yet among phase II patients, said Zeng, adding that more vaccine candidates will be approved to go into human trials in June.
I am aware of 4 of these vaccines (below). But the article did not name of the 5th vaccine maker.
- Cansino Biologics
- Sinovac
- Sinopharm / China National Biotec Group (CNBG) / Wuhan Institute of Biological Products (in collaboration with Wuhan Institute of Virology under the Chinese Academy of Sciences )
- Sinopharm / China National Biotec Group (CNBG) / Beijing Institute of Biological Products Co Ltd (in collaboration with China Center for Disease Control and Prevention)